Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation

被引：581

作者：

Kotton, Camille N. ^{[1
]}

Kumar, Deepali ^{[2
]}

Caliendo, Angela M. ^{[3
]}

Asberg, Anders ^{[4
]}

Chou, Sunwen ^{[5
]}

Danziger-Isakov, Lara ^{[6
]}

Humar, Atul ^{[7
]}

机构：

[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02114 USA

[2] Univ Alberta, Edmonton, AB, Canada

[3] Brown Univ, Alpert Med Sch Brown, Providence, RI 02912 USA

[4] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway

[5] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97201 USA

[6] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA

[7] Univ Alberta, Dept Med, Alberta Transplant Inst, Edmonton, AB, Canada

来源：

TRANSPLANTATION | 2013年 / 96卷 / 04期

关键词：

Cytomegalovirus; CMV; Ganciclovir; Prevention; Prophylaxis; Resistance; Treatment; Valganciclovir; T-CELL RESPONSES; DRUG-RESISTANT CYTOMEGALOVIRUS; EPSTEIN-BARR-VIRUS; EXTENDED VALGANCICLOVIR PROPHYLAXIS; BRONCHIOLITIS OBLITERANS SYNDROME; BRONCHOALVEOLAR LAVAGE FLUID; HEPATIC-ARTERY THROMBOSIS; MANNOSE-BINDING LECTIN; VS. ORAL GANCICLOVIR; LONG-TERM RECIPIENT;

D O I：

10.1097/TP.0b013e31829df29d

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ transplantation, resulting in significant morbidity, graft loss, and adverse outcomes. Management of CMV varies considerably among transplant centers but has been become more standardized by publication of consensus guidelines by the Infectious Diseases Section of The Transplantation Society. An international panel of experts was reconvened in October 2012 to revise and expand evidence and expert opinion-based consensus guidelines on CMV management, including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues. The following report summarizes the recommendations.

引用

页码：333 / 360

页数：28

共 272 条

[21] Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults [J].

Bernstein, DI ;

Schleiss, MR ;

Berencsi, K ;

Gonczol, E ;

Dickey, M ;

Khoury, P ;

Cadoz, M ;

Meric, C ;

Zahradnik, J ;

Duliege, AM ;

Plotkin, S .

JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (05) :686-690

[22] Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action [J].

Biron, KK ;

Harvey, RJ ;

Chamberlain, SC ;

Good, SS ;

Smith, AA ;

Davis, MG ;

Talarico, CL ;

Miller, WH ;

Ferris, R ;

Dornsife, RE ;

Stanat, SC ;

Drach, JC ;

Townsend, LB ;

Koszalka, GW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) :2365-2372

[23] Impact of a Preemptive Strategy After 3 Months of Valganciclovir Cytomegalovirus Prophylaxis in Kidney Transplant Recipients [J].

Blanco, Noemie Boillat ;

Pascual, Manuel ;

Venetz, Jean-Pierre ;

Nseir, Ghaleb ;

Meylan, Pascal R. ;

Manuel, Oriol .

TRANSPLANTATION, 2011, 91 (02) :251-255

[24] Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients [J].

Bodro, Marta ;

Sabe, Nuria ;

Llado, Laura ;

Baliellas, Carme ;

Niubo, Jordi ;

Castellote, Jose ;

Fabregat, Joan ;

Rafecas, Antoni ;

Carratala, Jordi .

LIVER TRANSPLANTATION, 2012, 18 (09) :1093-1099

[25]

Boeckh Michael, 2003, Herpes, V10, P12

[26] Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis [J].

Boivin, Guy ;

Goyette, Nathalie ;

Farhan, Mahdi ;

Ives, Jane ;

Elston, Robert .

JOURNAL OF CLINICAL VIROLOGY, 2012, 53 (03) :208-213

[27]

Boivin G, 2009, ANTIVIR THER, V14, P697

[28] Infectious Complications in Three Double Hand Recipients: Experience From a Single Center [J].

Bonatti, H. ;

Brandacher, G. ;

Margreiter, R. ;

Schneeberger, S. .

TRANSPLANTATION PROCEEDINGS, 2009, 41 (02) :517-520

[29] Association of Cytomegalovirus Infection and Disease With Recurrent Hepatitis C After Liver Transplantation [J].

Bosch, Wendelyn ;

Heckman, Michael G. ;

Pungpapong, Surakit ;

Diehl, Nancy N. ;

Shalev, Jefree A. ;

Hellinger, Walter C. .

TRANSPLANTATION, 2012, 93 (07) :723-728

[30]

BOWMAN JS, 1991, CLIN TRANSPLANT, V5, P294

← 1 2 3 4 5 6 7 8 9 10 →